CN116726309A - Monitoring method, monitoring equipment and mother tyre monitoring system - Google Patents

Monitoring method, monitoring equipment and mother tyre monitoring system Download PDF

Info

Publication number
CN116726309A
CN116726309A CN202210210671.5A CN202210210671A CN116726309A CN 116726309 A CN116726309 A CN 116726309A CN 202210210671 A CN202210210671 A CN 202210210671A CN 116726309 A CN116726309 A CN 116726309A
Authority
CN
China
Prior art keywords
infusion
data
target
vital sign
monitoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210210671.5A
Other languages
Chinese (zh)
Inventor
雷莹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edan Instruments Inc
Original Assignee
Edan Instruments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edan Instruments Inc filed Critical Edan Instruments Inc
Priority to CN202210210671.5A priority Critical patent/CN116726309A/en
Publication of CN116726309A publication Critical patent/CN116726309A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16804—Flow controllers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

The invention relates to the technical field of medical electronic equipment, and discloses a monitoring method, monitoring equipment and a mother tyre monitoring system. Wherein the method comprises the following steps: acquiring vital sign data of a lying-in woman and a fetus, and receiving infusion data of a target drug sent by an infusion device; analyzing vital sign data of the parturients and the fetuses, determining target infusion data of target medicaments and transmitting the target infusion data to an infusion device; receiving current infusion data fed back by an infusion device; vital sign data is displayed in a vital sign display area of the monitoring device and current infusion data is displayed in an infusion display area of the monitoring device. By implementing the invention, the automatic infusion of the medicine is realized, the frequent regulation of medical staff is avoided, and the monitoring efficiency is improved.

Description

Monitoring method, monitoring equipment and mother tyre monitoring system
Technical Field
The invention relates to the technical field of medical electronic equipment, in particular to a monitoring method, monitoring equipment and a mother tyre monitoring system.
Background
Oxytocin is a common medicine used in obstetrical infusion, and for pregnant women with unsmooth labor progress, oxytocin is instilled to accelerate the labor of the pregnant women, after the fetus is delivered, oxytocin is injected into the pregnant women, and uterine contraction is promoted to reduce the occurrence probability of postpartum hemorrhage. However, if the oxytocin instillation speed is too high, too much medicine is absorbed by the puerpera, and the puerpera is subjected to uterine contraction overfrequency, the long-time uterine contraction overfrequency easily influences the blood circulation of the placenta, so that the fetus is subjected to hypoxia and asphyxia, and even the puerpera uterus is likely to be cracked. Therefore, the dose of oxytocin and the monitoring of the parturients and fetuses in the drip-forcing process are very important.
At present, an infusion pump is generally adopted to control the number of drops, a special person nurses the infusion pump and regulates oxytocin, and meanwhile, the monitoring of uterine contraction, fetal heart, maternal heart rate, blood pressure and the like is carried out. If abnormal conditions of the puerpera and the fetus are observed in the infusion process, the dosage of oxytocin needs to be adjusted or stopped in time when the uterus is excessively contracted or the fetal heart rate is changed. However, uterine contractions are monitored by a fetal monitoring system, and oxytocin injection is controlled by an infusion device, which is an independent system, and the infusion device can only provide single infusion device information, and the fetal monitoring system is usually only provided with physiological information of pregnant women and part of marked cultural relics, so that the combined analysis of vital sign changes and input medicines of the puerpera and the fetus is not performed. The individual difference of oxytocin is great, and the proper oxytocin dosage of different puerperas can be different, if infusion can not be timely carried out or stopped, the fetus or puerpera is likely to be abnormal, and medical staff needs to frequently switch systems or walk to the puerpera to observe and adjust the oxytocin concentration, so that the monitoring efficiency of the medical staff is affected.
Disclosure of Invention
Therefore, the embodiment of the invention provides a monitoring method, monitoring equipment and a mother tyre monitoring system, which are used for solving the problem of low monitoring efficiency of medical staff caused by manual adjustment of oxytocin.
According to a first aspect, an embodiment of the present invention provides a monitoring method, applied to a monitoring device, where the method includes: acquiring vital sign data of a lying-in woman and a fetus, and receiving infusion data of a target drug sent by an infusion device; analyzing vital sign data of the parturients and the fetuses, determining target infusion data of the target drugs and sending the target infusion data to the infusion device; receiving current infusion data fed back by the infusion device; and displaying the vital sign data in a vital sign display area of the monitoring device, and displaying the current infusion data in an infusion display area of the monitoring device.
According to the monitoring method provided by the embodiment of the invention, the vital sign data and the infusion data are displayed on the same monitoring device at the same time, namely, the monitoring device can perform joint observation on the vital sign data and the infusion data so as to perform joint analysis on the vital sign data of the lying-in women and the fetus, further determine the influence of the infusion data on the vital sign, conveniently determine the target infusion data of the target medicine according to the change of the vital sign, send the target infusion data to the infusion device, and adjust the infusion state of the target medicine by the infusion device, thereby realizing automatic infusion of the medicine and avoiding frequent adjustment of medical staff. After the monitoring device receives the current infusion data fed back by the infusion device, vital sign data are displayed in the vital sign display area of the monitoring device, and the current infusion data are displayed in the infusion display area of the monitoring device, so that medical staff can know vital sign conditions of a lying-in woman and a fetus and infusion conditions of the infusion device conveniently, the medical staff can obtain corresponding information, and monitoring efficiency is improved.
With reference to the first aspect, in a first implementation manner of the first aspect, the analyzing vital sign data of the maternal and fetal, determining target infusion data of the target drug and transmitting the target infusion data to the infusion device includes: determining whether the uterine contraction characteristic value of the puerpera reaches a preset value based on the vital sign data; when the uterine contraction characteristic value does not reach the preset value, determining the increment of a target drug based on the current uterine contraction characteristic value, and obtaining first target infusion data corresponding to the current uterine contraction characteristic value; the first target infusion data is sent to the infusion device.
With reference to the first embodiment of the first aspect, in a second implementation of the first aspect, the analyzing vital sign data of the maternal and fetal, determining target infusion data of the target drug and transmitting the target infusion data to the infusion device further includes: when the uterine contraction characteristic value reaches the preset value, determining the holding quantity, the increasing quantity or the decreasing quantity of the target drug based on the current uterine contraction characteristic value, and obtaining second target infusion data corresponding to the current uterine contraction characteristic value; the second target infusion data is sent to the infusion device.
According to the monitoring method provided by the embodiment of the invention, in the monitoring process, the vital sign data of the puerpera and the fetus are monitored in real time to determine the uterine contraction condition of the puerpera, and the infusion data of the target medicine is regulated according to the uterine contraction condition of the puerpera, so that the effect of effective uterine contraction can be achieved by less target medicine, and the fetus is promoted to be delivered.
With reference to the second implementation manner of the first aspect, in a third implementation manner of the first aspect, the method further includes: detecting whether vital sign abnormality occurs in the lying-in woman and the fetus; when vital signs of the puerpera and the fetus are abnormal, alarm information is sent, and information for reducing the target drug infusion quantity is sent to the infusion equipment.
According to the monitoring method provided by the embodiment of the invention, when the uterine contraction state of the puerpera is good but vital signs of the puerpera and the fetus are abnormal, alarm information is sent out so that medical staff can observe the abnormality in time and perform intervention treatment. And sending information for reducing the infusion quantity of the target medicine to the infusion equipment while sending alarm information so as to avoid the influence of the infusion of the target medicine on the lying-in woman and the fetus.
With reference to the first implementation manner of the first aspect, in a fourth implementation manner of the first aspect, the analyzing vital sign data of the maternal and fetal, determining target infusion data of the target drug and transmitting the target infusion data to the infusion device, further includes: detecting whether the uterine contraction frequency of the parturient exceeds a preset frequency based on the vital sign data; and when the uterine contraction frequency of the puerpera exceeds a preset frequency, sending information for reducing or stopping the target medicine infusion quantity to the infusion device.
According to the monitoring method provided by the embodiment of the invention, when the uterine contraction frequency of the puerpera exceeds the preset frequency, namely, the uterine contraction frequency of the puerpera, the information for reducing or stopping the target drug infusion amount is sent to the infusion equipment until the uterine contraction frequency is resolved, so that the condition of fetal hypoxia is avoided, and the stability of fetal vital signs is ensured.
With reference to the fourth implementation manner of the first aspect, in a fifth implementation manner of the first aspect, the method further includes: when the current infusion data fed back by the infusion device is zero, detecting whether the uterine contraction frequency of the puerpera exceeds a preset frequency; when the uterine contraction frequency of the puerpera exceeds a preset frequency, prompt information is sent to the operation object, and the prompt information is used for reminding the operation object to perform intervention treatment.
According to the monitoring method provided by the embodiment of the invention, when the target medicine stops infusing and the uterine contraction of the puerpera is still over-frequent, prompt information is sent to the operation object at the moment, so that the operation object can be conveniently and timely intervened, and the condition of fetal hypoxia is further avoided.
With reference to the first implementation manner of the first aspect, in a sixth implementation manner of the first aspect, the method further includes: determining a waiting time period of the parturient based on the vital sign data; when the waiting time exceeds a preset time and the uterine contraction characteristic value does not reach the preset value, sending prompt information to an operation object; and sending infusion starting information to the infusion device in response to the confirmation operation of the operation object on the prompt information.
According to the monitoring method provided by the embodiment of the invention, under the condition that the puerpera is to be produced for a long time and the uterine contraction is not strong, the prompt information is sent to the operation object so as to remind the operation object to care the puerpera and infuse the target medicine, after the prompt information is confirmed by the operation object, the monitoring equipment sends the infusion starting information to the infusion equipment so that the infusion equipment starts to infuse the target medicine to the puerpera, and the influence of long time to be produced on fetal delivery is avoided.
With reference to any one of the first to sixth embodiments of the first aspect, in a seventh embodiment of the first aspect, the method further includes: and responding to the selection operation of the operation object on the transfusion display area, and displaying the uterine contraction states of the target medicine and the puerperal women.
According to the monitoring method provided by the embodiment of the invention, the target medicine and the uterine contraction state of the puerpera are displayed in the infusion display area, so that medical staff can know the influence of the infused medicine on vital signs of the puerpera conveniently, and the monitoring method is used for assisting in clinical accurate care.
With reference to the first aspect, in an eighth implementation manner of the first aspect, the infusion data includes a drug dripping speed, the vital sign data is displayed in a vital sign display area of the monitoring device, the current infusion data is displayed in an infusion display area of the monitoring device, and the method includes: and displaying the vital sign data in a vital sign display area of the monitoring device, and displaying the current medicine dripping speed in an infusion display area of the monitoring device.
According to the monitoring method provided by the embodiment of the invention, the vital sign data and the current medicine dripping speed are displayed simultaneously, so that medical staff can conveniently observe the influence of the medicine dripping speed on the vital sign data, a plurality of different systems are not required to be operated simultaneously, and the workload of the medical staff is reduced.
With reference to the eighth implementation manner of the first aspect, in a ninth implementation manner of the first aspect, the method further includes: and labeling the abnormal data in the monitoring process in response to the labeling operation of the operation object on the vital sign data.
According to the monitoring method provided by the embodiment of the invention, the abnormal data in the monitoring process are marked, so that the follow-up adjustment of the infusion quantity of the medicine by analyzing the abnormal data is facilitated.
With reference to the eighth implementation manner of the first aspect, in a tenth implementation manner of the first aspect, the method further includes: monitoring record information is generated based on the infusion data of the target medicine and vital sign data of the parturient and the fetus.
According to the monitoring method provided by the embodiment of the invention, after the monitoring is finished, the monitoring record information is generated according to the infusion data of the target medicine and the vital sign data of the puerpera and the fetus in the monitoring process, so that the electronization of the medicine record in the monitoring process is realized.
According to a second aspect, an embodiment of the present invention provides a monitoring device, including: the monitoring system comprises a display interface, a memory and a processor, wherein the display interface, the memory and the processor are in communication connection, the memory stores computer instructions, and the processor executes the computer instructions so as to execute the monitoring method according to the first aspect or any implementation mode of the first aspect.
The monitoring device provided by the embodiment of the invention has the advantages that the vital sign data and the infusion data are simultaneously displayed on the same monitoring device, namely, the monitoring device can perform joint observation on the vital sign data and the infusion data so as to perform joint analysis on the vital sign data of the lying-in women and the fetus, further determine the influence of the infusion data on the vital sign, conveniently determine the target infusion data of the target medicine according to the change of the vital sign, send the target infusion data to the infusion device, and adjust the infusion state of the target medicine by the infusion device, thereby realizing automatic infusion of the medicine and avoiding frequent adjustment of medical staff. After the monitoring device receives the current infusion data fed back by the infusion device, vital sign data are displayed in the vital sign display area of the monitoring device, and the current infusion data are displayed in the infusion display area of the monitoring device, so that medical staff can know vital sign conditions of a lying-in woman and a fetus and infusion conditions of the infusion device conveniently, the medical staff can obtain corresponding information, and monitoring efficiency is improved.
According to a third aspect, an embodiment of the present invention provides a maternal-fetal monitoring system, comprising: an infusion device for acquiring infusion data of a target drug; the monitoring device of the second aspect is communicatively coupled to the infusion device.
According to the maternal and fetal monitoring system provided by the embodiment of the invention, vital sign data of a puerpera and a fetus acquired by the monitoring equipment and infusion data of the infusion equipment are simultaneously displayed on the same monitoring equipment, namely, the vital sign data and the infusion data of the infusion equipment are jointly observed, so that the vital sign change is jointly analyzed, the target infusion data of a target medicine can be conveniently determined according to the vital sign change, automatic infusion of the medicine is realized, and frequent adjustment of medical staff is avoided. Meanwhile, medical staff can know vital sign conditions and infusion equipment conditions of a target object conveniently, and monitoring efficiency is improved.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings that are needed in the description of the embodiments or the prior art will be briefly described, and it is obvious that the drawings in the description below are some embodiments of the present invention, and other drawings can be obtained according to the drawings without inventive effort for a person skilled in the art.
Fig. 1 is a schematic hardware structure of a monitoring device according to an embodiment of the present invention;
FIG. 2 is a block diagram of a maternal-fetal monitoring system provided according to an embodiment of the present invention;
FIG. 3 is a schematic diagram of a maternal-fetal monitoring system provided according to an embodiment of the present invention;
FIG. 4 is another schematic diagram of a maternal-fetal monitoring system provided according to an embodiment of the present invention;
FIG. 5 is another schematic diagram of a maternal-fetal monitoring system provided according to an embodiment of the present invention;
FIG. 6 is a flow chart of a monitoring method according to an embodiment of the invention;
FIG. 7 is another flow chart of a monitoring method according to an embodiment of the present invention;
FIG. 8 is another flow chart of a monitoring method according to an embodiment of the present invention;
FIG. 9 is a schematic diagram of a monitoring device display interface according to an embodiment of the present invention;
fig. 10 is a schematic view of an infusion display interface according to an embodiment of the invention.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present invention more apparent, the technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention, and it is apparent that the described embodiments are some embodiments of the present invention, but not all embodiments of the present invention. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
According to the monitoring method provided by the embodiment of the invention, the vital sign data and the infusion data of the puerpera and the fetus are monitored in a combined way, so that the real-time display of the vital sign and the infusion information is realized, and the vital sign condition of the puerpera and the infusion condition of the medicine can be monitored by medical staff conveniently. Meanwhile, the monitoring device can monitor the influence of the infusion data on vital signs in real time so as to determine the target infusion data of the target medicine according to the change of the vital signs, and send the target infusion data to the infusion device, and the infusion state of the target medicine is adjusted by the infusion device, so that automatic infusion of the medicine is realized, and frequent adjustment of medical staff is avoided. In addition, vital sign data and infusion data are simultaneously displayed on the same monitoring main interface, so that medical staff can obtain corresponding information, and simultaneous operation of a plurality of different systems is avoided.
Furthermore, an analysis method for simultaneously displaying vital sign data and drug infusion data is provided in the monitoring method, so that medical staff can evaluate the relationship between infused drugs and vital sign changes of a lying-in woman and a fetus conveniently, clinical decisions can be made timely, and treatment risks are reduced.
Furthermore, the infusion quantity of the medicine can be automatically regulated by combining the uterine contraction condition of the puerpera in the monitoring method, meanwhile, the infusion quantity of the medicine can be timely reduced and medical staff can be reminded when abnormal conditions occur, individual differential management of the puerpera and standardized management of clinical medicine infusion are realized, the workload of the medical staff is reduced, the medical staff is ensured to intensively care the puerpera and the fetus, and the childbirth experience of the puerpera is promoted.
Furthermore, better uterine contraction effect can be realized by a smaller amount of medicine to the greatest extent in the monitoring method, and the occurrence of medicine complications and abnormal fetal heart rate is reduced to a certain extent.
The embodiment of the invention provides a monitoring device which is connected with an infusion device, wherein the infusion device is used for acquiring infusion data of a target drug, and the monitoring device is used for monitoring vital sign data of a lying-in woman and a fetus. The monitoring device acquires infusion data from the infusion device and displays the vital sign data and the infusion data monitored by the monitoring device in a vital sign display area and an infusion display area of the monitoring device.
The monitoring equipment and the infusion equipment can be arranged in a puerpera ward, each monitoring equipment can simultaneously receive infusion pump information corresponding to different infusion equipment, namely, the monitoring equipment can simultaneously carry out information interaction with a plurality of infusion equipment. Of course, the number of infusion devices that can perform information interaction with the monitoring device at most can be set according to actual requirements, and the number of infusion devices is not limited in any way.
The monitoring equipment also has a man-machine interaction function, and medical staff infuses certain medicines for the puerpera and sets the infusion speed by operating the monitoring equipment, and monitors vital sign data of the puerpera and the fetus at the same time, so that vital signs of the puerpera and the fetus are ensured to be normal in the infusion process. Likewise, medical staff can jointly observe vital sign data and infusion data of puerpera and fetus through operating the monitoring equipment so as to intervene in drug infusion according to the change of the vital sign data, thereby avoiding the medical staff from acquiring information from two different equipment and reducing the workload of the medical staff.
The specific monitoring method regarding the monitoring device will be described in detail below.
Fig. 1 is a schematic structural diagram of a monitoring device according to an alternative embodiment of the present invention, and as shown in fig. 1, the monitoring device may include: at least one processor 101, such as a CPU (Central Processing Unit ), at least one communication interface 103, a memory 104, at least one communication bus 102, and a display interface (not shown in fig. 1). Wherein the communication bus 102 is used to enable connected communication between these components. The communication interface 103 may include a Display screen (Display) and a Keyboard (Keyboard), and the selectable communication interface 103 may further include a standard wired interface and a wireless interface. The memory 104 may be a high-speed RAM memory (Random Access Memory, volatile random access memory) or a non-volatile memory (non-volatile memory), such as at least one disk memory. The memory 104 may also optionally be at least one storage device located remotely from the aforementioned processor 101. Wherein the memory 104 stores an application program and the processor 101 invokes program code stored in the memory 104 for performing the steps of any of the monitoring methods described below.
The communication bus 102 may be a peripheral component interconnect standard (peripheral component interconnect, PCI) bus or an extended industry standard architecture (extended industry standard architecture, EISA) bus, among others. The communication bus 102 may be classified as an address bus, a data bus, a control bus, or the like. For ease of illustration, only one thick line is shown in fig. 1, but not only one bus or one type of bus.
The memory 104 may include volatile memory (english) such as random-access memory (RAM); the memory may also include a nonvolatile memory (english: non-volatile memory), such as a flash memory (english: flash memory), a hard disk (english: hard disk drive, abbreviated as HDD) or a solid state disk (english: solid-state drive, abbreviated as SSD); the memory 104 may also include a combination of the types of memory described above.
The processor 101 may be a central processor (English: central processing unit, abbreviated: CPU), a network processor (English: network processor, abbreviated: NP) or a combination of CPU and NP.
The processor 101 may further include a hardware chip. The hardware chip may be an application-specific integrated circuit (ASIC), a Programmable Logic Device (PLD), or a combination thereof (English: programmable logic device). The PLD may be a complex programmable logic device (English: complex programmable logic device, abbreviated: CPLD), a field programmable gate array (English: field-programmable gate array, abbreviated: FPGA), a general-purpose array logic (English: generic array logic, abbreviated: GAL), or any combination thereof.
Optionally, the memory 104 is also used for storing program instructions. The processor 101 may invoke program instructions to implement the monitoring method as shown in any of the embodiments of the present application.
The monitoring device provided by the embodiment displays vital sign data and infusion data on the same monitoring device at the same time, namely, the monitoring device can perform joint observation on the vital sign data and the infusion data so as to perform joint analysis on the vital sign data of a lying-in woman and a fetus, further determine the influence of the infusion data on the vital sign, be convenient for determining the target infusion data of the target medicine according to the change of the vital sign, send the target infusion data to the infusion device, and adjust the infusion state of the target medicine by the infusion device, thereby realizing automatic infusion of the medicine and avoiding frequent adjustment of medical staff. After the monitoring device receives the current infusion data fed back by the infusion device, vital sign data are displayed in the vital sign display area of the monitoring device, and the current infusion data are displayed in the infusion display area of the monitoring device, so that medical staff can know vital sign conditions of a lying-in woman and a fetus and infusion conditions of the infusion device conveniently, the medical staff can obtain corresponding information, and monitoring efficiency is improved.
The embodiment of the invention also provides a maternal and fetal monitoring system, as shown in fig. 2, which comprises an infusion device 21 and a monitoring device 22. For a detailed description of the monitoring device 22, please refer to the above description, and the detailed description is omitted.
Specifically, the infusion device 21 is used to acquire infusion data of a target drug; the monitoring device 22 is in communication with the infusion device 21 for acquiring infusion data corresponding to the parturient. Wherein the infusion device 21 may comprise a plurality of infusion pumps, as shown in fig. 3, the monitoring device 22 may be wired or wireless to enable a communication connection with the plurality of infusion pumps. The infusion device 21 may also include an infusion control system communicatively coupled to the infusion pumps, as shown in fig. 4, and the plurality of monitoring devices 22 may be wired or wirelessly coupled to the infusion control system, which in turn may be wired or wirelessly coupled to the plurality of infusion pumps to effect a communicative coupling between the monitoring devices 22 and the infusion device 21. Of course, the monitoring device 22 may also include a monitoring control system and a plurality of monitors, as shown in fig. 5, where the plurality of monitors are wired or wirelessly connected to the monitoring control system, and the monitoring control system is wired or wirelessly connected to the infusion control system, and the infusion control system may be wired or wirelessly connected to a plurality of infusion pumps, thereby implementing a communication connection between the monitoring device 22 and the infusion device 21. Of course, other communication connections are possible and are not specifically limited herein.
Wherein a hardware communication connection between the infusion device 21 and the monitoring device 22 needs to be established before a communication connection of the infusion device 21 and the monitoring device 22 is made. Specifically, firstly, an internal data interface of the infusion device 21 (infusion control system and/or infusion pump) is opened, and according to the type of the internal data interface of the infusion device 21, the data transmission interface is converted into an external communication interface such as a serial port/internet port/Wi-Fi by a hardware switching mode. The monitoring device 22 is generally configured with various interfaces and communication protocols, and can set corresponding communication protocols and connection modes according to the type of the internal data interface of the infusion device 21, and then establish communication connection with the infusion device 21 in a wired/wireless manner to realize data interaction. The monitoring device 22 communicates parameter data streams via a connection handshake with the infusion device 21, configuration data packets. The infusion device 21 detects whether its channel/port is occupied, and if it is idle, it transmits data frame information. After receiving the data frame information sent by the infusion device 21, the monitoring device 22 sends acknowledgement frame information to the infusion device 21, and after successful handshake, the two devices can perform data interaction through a predetermined communication protocol.
After the infusion device 21 and the monitoring device 22 are powered on, they are able to communicate data and establish a connection. According to the device numbers and network port numbers corresponding to different infusion devices 21, one monitoring device 22 can receive the infusion data from different infusion devices 21 at the same time, and perform information interaction with multiple infusion devices 21. Specific data interconnection schematics refer to fig. 3-5.
The infusion device 21 serves as a data transmitting end for transmitting infusion data to the monitoring device 22 at a fixed period (e.g., timing 1S). The infusion device 21 also receives data from the monitoring device 22 in real time, adjusts the infusion of the drug based on the data, and transmits information such as drug information, drug concentration, drug drip rate, etc., to the monitoring device 22.
The monitoring device 22 is used as a receiving end, receives the data sent by the infusion device 21, and can send control instructions to the infusion device 21 after the vital sign data and the infusion data of the puerpera and the fetus are subjected to joint analysis, such as lowering the concentration of the medicine to a certain value, raising the concentration of the medicine to a certain value and the like, so that intelligent infusion of the medicine is realized, and frequent manual adjustment of medical staff is avoided. The monitoring device 22 receives the current infusion data fed back by the infusion device 21 and displays the current infusion data on a display interface of the current infusion data, so that medical staff is prevented from operating the two devices simultaneously to acquire different information, the workload of the medical staff is reduced, the puerpera can be intensively nursed, and the monitoring efficiency is improved.
According to the maternal and fetal monitoring system provided by the embodiment, vital sign data of a puerpera and a fetus collected by the monitoring device and infusion data of the infusion device are displayed on the same monitoring device at the same time, namely, the vital sign data and the infusion data of the infusion device are jointly observed, so that the vital sign change is jointly analyzed, the target infusion data of a target drug is conveniently determined according to the change of the vital sign, automatic infusion of the drug is realized, and frequent adjustment of medical staff is avoided. Meanwhile, medical staff can know vital sign conditions and infusion equipment conditions of a target object conveniently, and monitoring efficiency is improved.
In accordance with an embodiment of the present invention, there is provided an embodiment of a monitoring method, it being noted that the steps shown in the flowcharts of the figures may be performed in a computer system, such as a set of computer executable instructions, and that, although a logical order is shown in the flowcharts, in some cases, the steps shown or described may be performed in an order other than that shown or described herein.
In this embodiment, a monitoring method is provided, which may be used in the monitoring device described above, and fig. 6 is a flowchart of the monitoring method according to an embodiment of the present invention, as shown in fig. 6, where the flowchart includes the following steps:
S11, acquiring vital sign data of a puerpera and a fetus, and receiving infusion data of a target drug sent by an infusion device.
The monitoring device can monitor and acquire vital sign data of the lying-in woman and the fetus in real time, and is in communication connection with the infusion device, and the monitoring device can also receive the infusion data of the target medicine sent by the infusion device when monitoring the vital sign data of the lying-in woman and the fetus. Wherein the target drug is a therapeutic drug for promoting fetal delivery by a parturient, such as oxytocin.
In particular, the monitoring device may parse the data sent by the infusion device based on a communication protocol between the monitoring device and the infusion device to obtain infusion data for the target drug, which may include drug type, drug concentration, etc. In the infusion process, medical staff infuses a certain type of target medicine for the puerpera according to the doctor's advice and sets corresponding infusion speed, and the monitoring equipment can acquire the infusion data of the target medicine while monitoring the vital sign data of the puerpera and the fetus so as to ensure that the vital signs of the puerpera and the fetus are normal in the target medicine infusion process. The vital sign data include, but are not limited to, fetal heart rate, maternal blood pressure, maternal blood oxygen, etc., and of course, various vital sign parameters may be set according to actual needs, which are not limited herein.
S12, analyzing vital sign data of the puerpera and the fetus, determining target infusion data of the target medicine and sending the target infusion data to the infusion device.
The monitoring device can perform joint analysis on vital sign data and infusion data of the puerpera and the fetus collected by the monitoring device to determine the influence of the infusion data on the vital sign, then determine target infusion data of target drugs infused to the puerpera to promote the fetus to be delivered according to the change condition of the vital sign data, and send the target infusion data to the infusion device so that the infusion device executes corresponding infusion operation when receiving an infusion instruction corresponding to the target infusion data.
S13, receiving current infusion data fed back by the infusion device.
After the infusion device adjusts its infusion data according to the target infusion data, for example, increases the target drug infusion amount, decreases the target drug infusion amount, the infusion device may feed back the current infusion data of the target drug to the monitoring device after the adjustment of the infusion data is completed. Accordingly, the monitoring device may then receive current infusion data fed back by the infusion device.
S14, vital sign data is displayed in a vital sign display area of the monitoring device, and current infusion data is displayed in an infusion display area of the monitoring device.
The display interface of the monitoring device comprises a vital sign display area and an infusion display area, the monitoring device displays the vital sign data acquired by the monitoring device in the vital sign display area, and the current infusion data fed back by the infusion device received by the monitoring device is displayed in the infusion display area. As shown in fig. 9, the vital sign display area displays various vital sign data, and the infusion display area displays the dripping speed of the target drug (oxytocin, for example). Note that, for vital sign data, the real-time data may be displayed in a waveform or a data value, and fig. 9 is only an example and does not limit the protection scope of the present invention.
According to the monitoring method provided by the embodiment, the vital sign data and the infusion data are displayed on the same monitoring device at the same time, namely, the vital sign data and the infusion data can be jointly observed by the monitoring device, so that the vital sign data of a lying-in woman and a fetus are jointly analyzed, the influence of the infusion data on the vital sign is further determined, the target infusion data of a target medicine is conveniently determined according to the change of the vital sign, the target infusion data is sent to the infusion device, and the infusion state of the target medicine is adjusted by the infusion device, so that automatic infusion of the medicine is realized, and frequent adjustment of medical staff is avoided. After the monitoring device receives the current infusion data fed back by the infusion device, vital sign data are displayed in the vital sign display area of the monitoring device, and the current infusion data are displayed in the infusion display area of the monitoring device, so that medical staff can know vital sign conditions of a lying-in woman and a fetus and infusion conditions of the infusion device conveniently, the medical staff can obtain corresponding information, and monitoring efficiency is improved.
In this embodiment, a monitoring method is provided, which may be used in the monitoring device described above, and fig. 7 is a flowchart of the monitoring method according to an embodiment of the present invention, as shown in fig. 7, where the flowchart includes the following steps:
s21, vital sign data of the puerpera and the fetus are acquired, and infusion data of the target medicine sent by the infusion equipment are received. The detailed description refers to the corresponding related descriptions of the above embodiments, and will not be repeated here.
S22, analyzing vital sign data of the puerpera and the fetus, determining target infusion data of the target medicine and sending the target infusion data to the infusion device.
Specifically, the step S22 may include:
s221, determining the uterine contraction characteristic value of the puerpera based on vital sign data.
The monitoring device can analyze whether the uterine contraction characteristic value of the puerpera reaches a preset value or not based on vital sign data acquired by the monitoring device. Specifically, the monitoring device may obtain the contraction characteristic value according to the acquired monitoring start time, monitoring duration, contraction start/end time, contraction duration, contraction interval and contraction intensity of the puerpera, and then determine the current contraction state of the puerpera according to the contraction characteristic value. The uterine contraction characteristic value may include a uterine contraction maintaining period, a uterine cavity pressure, a uterine contraction intermittent period, and the like, which are not particularly limited herein.
And S222, determining the increment of the target drug based on the current uterine contraction characteristic value when the uterine contraction characteristic value does not reach the preset value, and obtaining first target infusion data corresponding to the current uterine contraction characteristic value.
The monitoring device compares the obtained uterine contraction characteristic value with a preset value to determine whether the uterine contraction characteristic value reaches the preset value. When the uterine contraction characteristic value does not reach the preset value, the monitoring device can determine the infusion increment of the target medicine, namely, first target infusion data corresponding to the current uterine contraction characteristic value, in the set threshold range of the target medicine.
Taking the uterine contraction characteristic values including the uterine contraction maintaining time, the uterine cavity pressure and the uterine contraction intermittent period as examples, the conventional uterine contraction maintaining time is required to be 30-40 seconds/3-5 minutes, the uterine cavity pressure is more than or equal to 50-60 mmHg, and the uterine contraction intermittent period is more than or equal to 1 minute. Of course, the uterine contraction characteristic value may also include other characteristic parameters, which are not particularly limited herein.
Optionally, when the uterine contraction characteristic value of the parturient does not reach the preset value, the method further comprises:
(1) And determining the waiting time length of the puerpera based on the vital sign data.
The monitoring device can determine the current state of the puerpera according to the collected vital sign data, and then can determine the puerpera waiting time according to the monitoring starting time and the monitoring time collected by the monitoring device.
(2) And when the waiting time exceeds the preset time and the uterine contraction characteristic value does not reach the preset value, sending prompt information to the operation object.
The preset duration is the set duration of the waiting period, and the monitoring equipment compares the acquired waiting period of the lying-in woman with the preset duration to determine whether the waiting period exceeds the preset duration. And when the waiting time exceeds the preset time, sending prompt information to the operation object. The prompting information can be text prompting, voice prompting or other prompting modes, and is not particularly limited herein; the operation object is a medical staff for nursing the puerpera.
(3) And sending the infusion starting information to the infusion device in response to the confirmation operation of the operation object on the prompt information.
After receiving the prompt information sent by the monitoring device, the operator can check vital sign data of the parturient and the fetus to determine whether to infuse target medicines. When the target medicine needs to be infused, the operation object can confirm the prompt information. Accordingly, the monitoring device can respond to the confirmation operation of the operation object on the prompt information and send the infusion starting information to the infusion device so that the infusion device infuses according to the preset dosage of the target medicine.
S223, the first target infusion data is sent to the infusion device.
The monitoring device generates an infusion instruction based on the first target infusion data and sends the infusion instruction to the infusion device, so that when the infusion device receives the infusion instruction, the infusion device increases the infusion quantity of the target medicine according to the first target infusion data carried by the infusion instruction until the uterine contraction characteristic value reaches a preset value. For example, the infusion device may increase by 5 drops/minute at 15-40 minutes intervals upon receiving an infusion command from the monitoring device, and the increase in the target medication is merely exemplary and does not limit the scope of the present invention.
And S224, when the uterine contraction characteristic value reaches a preset value, determining the holding amount, the increasing amount or the decreasing amount of the target drug based on the current uterine contraction characteristic value, and obtaining second target infusion data corresponding to the current uterine contraction characteristic value.
The monitoring device compares the obtained uterine contraction characteristic value with a preset value to determine whether the uterine contraction characteristic value reaches the preset value. When the uterine contraction characteristic value reaches a preset value, namely the infusion of the target medicine reaches an effective infusion amount, the monitoring device can determine the holding amount, the increasing amount or the decreasing amount of the target medicine according to the uterine contraction condition of the puerpera, and second target infusion data corresponding to the current uterine contraction characteristic value is obtained.
Optionally, while the uterine contraction characteristic value is maintained at the preset value, the method further comprises:
(1) Detecting whether the vital sign of the parturient and the fetus is abnormal.
If the uterine contraction state of the puerpera is maintained better in the process of infusing the target medicine, the monitoring equipment continuously collects vital sign data of the puerpera and the fetus at the moment and analyzes the vital sign data collected by the monitoring equipment to determine whether the puerpera and the fetus have abnormal vital signs or not.
(2) When vital signs of the puerpera and the fetus are abnormal, alarm information is sent, and information for reducing the target drug infusion amount is sent to the infusion equipment.
When the monitoring device detects that vital signs of the puerpera and the fetus are abnormal, such as abnormal fetal heart rate, puerpera heart rate, blood pressure and the like, the monitoring device can send out alarm information at the moment so that medical staff can intervene and process in time. And simultaneously, information for reducing the infusion quantity of the target medicine is sent to the infusion device, so that the infusion device reduces the infusion quantity of the target medicine and reduces the influence of the target medicine on vital signs.
And S225, transmitting second target infusion data to the infusion device.
The monitoring device may generate an infusion instruction based on the second target infusion data and send the infusion instruction to the infusion device, so that when the infusion instruction is received by the infusion device, the infusion device maintains the infusion amount of the target drug, increases the infusion amount of the target drug or decreases the infusion amount of the target drug according to the target infusion data carried by the infusion instruction, so as to maintain effective uterine contraction of the parturient and promote delivery of the fetus.
S226, detecting whether the uterine contraction frequency of the puerpera exceeds a preset frequency based on vital sign data.
In the process of infusing the target medicine, the monitoring equipment collects vital sign data of the lying-in women and fetuses in real time and analyzes the vital sign data of the lying-in women to determine whether the phenomenon that the uterine contraction frequency exceeds the preset frequency occurs after the target medicine is infused. The preset frequency is a set maximum contraction frequency, the preset frequency can be set to be an average contraction frequency within 30min or not more than 5 times within 10min, the preset frequency is not particularly limited, and the preset frequency can be adjusted according to actual scenes.
When the uterine contraction frequency of the parturient exceeds the preset frequency, step S227 is performed, otherwise the infusion state of the target drug is continuously maintained, and the uterine contraction frequency of the parturient is continuously detected.
S227, information is sent to the infusion device to reduce or stop the target drug infusion amount.
When the uterine contraction frequency of the puerpera exceeds the preset frequency, the uterine contraction frequency of the puerpera is represented, and the preset frequency is taken as an example, namely, the uterine contraction frequency of the puerpera is larger than 5 times in every 10min in average within 30 min. At this time, even if the monitoring device does not detect abnormal fetal heart rate, in order to avoid fetal hypoxia, the monitoring device still needs to send information for reducing or stopping the infusion amount of the target drug to the infusion device, so that the infusion device gradually reduces the infusion amount of the target drug, even stops the infusion, until the uterine contraction overfrequency phenomenon is resolved.
Optionally, when stopping the infusion of the target medicine to the puerpera, that is, when receiving the current infusion data fed back by the infusion device, the method continues to detect whether the uterine contraction frequency of the puerpera exceeds the preset frequency; and when the uterine contraction frequency of the puerpera exceeds the preset frequency, sending prompt information to the operation object.
The prompt information is used for reminding the operation object to perform intervention processing.
Typically, the efficacy of the target drug gradually declines after a period of time following cessation of the infusion of the drug, for the example of oxytocin, and after 20 minutes following cessation of the infusion of oxytocin. When the current infusion data fed back by the infusion device is 0, the monitoring device indicates that the infusion of the target medicine is stopped, and at the moment, the monitoring device continuously monitors vital sign data of the puerpera and the fetus so as to determine whether the uterine contraction frequency of the puerpera is relieved after the infusion of the target medicine is stopped. If the uterine contraction frequency of the puerpera still exceeds the preset frequency, namely the uterine contraction frequency is not relieved, the monitoring equipment can send prompt information to the operation object at the moment so as to remind the operation object to perform intervention treatment on the puerpera, and the vital signs of the puerpera and the fetus can be guaranteed to be recovered to be normal in time.
When the target medicine stops infusing and the uterine contraction of the puerpera is still over-frequent, prompt information is sent to the operation object at the moment, so that the operation object can intervene in time, and the condition of fetal hypoxia is further avoided.
Optionally, during infusion monitoring of the target drug, the monitoring method further comprises: and displaying the uterine contraction states of the target medicine and the puerpera in response to the selection operation of the operation object on the transfusion display area.
In the infusion monitoring process of the target medicine, when the operation object needs to check the association relation between the current infusion data and the uterine contraction state, the infusion display area can be selected, and accordingly, the monitoring device can respond to the selection operation of the infusion display area to display the real-time data of the current infusion data and the uterine contraction state, as shown in fig. 10. It should be noted that, fig. 10 is only an example, and the association between the current infusion data and the uterine contraction status may be displayed in other manners, which is not limited herein.
By displaying the target medicine and the uterine contraction state of the puerpera in the infusion display area, medical staff can know the influence of the infused medicine on vital signs of the puerpera conveniently, and the infusion display area is used for assisting in clinical accurate nursing.
S23, receiving current infusion data fed back by the infusion device. The detailed description refers to the corresponding related descriptions of the above embodiments, and will not be repeated here.
And S24, displaying vital sign data in a vital sign display area of the monitoring device, and displaying current infusion data in an infusion display area of the monitoring device. The detailed description refers to the corresponding related descriptions of the above embodiments, and will not be repeated here.
According to the monitoring method provided by the embodiment, in the monitoring process, vital sign data of the puerpera and the fetus are monitored in real time to determine the uterine contraction condition of the puerpera, and the infusion data of the target medicine is adjusted according to the uterine contraction condition of the puerpera, so that the effect of effective uterine contraction can be achieved by less target medicine, and the fetus is promoted to be delivered. When the uterine contraction state of the puerpera is good but vital signs of the puerpera and the fetus are abnormal, alarm information is sent so that medical staff can observe the abnormality in time and intervene, and information for reducing the infusion quantity of the target medicine is sent to the infusion equipment while the alarm information is sent so as to avoid the influence of the infusion of the target medicine on the puerpera and the fetus. When the uterine contraction frequency of the puerpera exceeds the preset frequency, information for reducing or stopping the target drug infusion amount is sent to the infusion equipment until the uterine contraction frequency subsides, so that the condition of fetal hypoxia is avoided, and the stability of fetal vital signs is ensured. And the infusion display area displays the target medicine and the uterine contraction state of the puerpera, so that medical staff can know the influence of the infused medicine on vital signs of the puerpera conveniently, and the infusion display area is used for assisting in clinical accurate nursing.
In this embodiment, a monitoring method is provided, which may be used in the monitoring device described above, and fig. 8 is a flowchart of the monitoring method according to an embodiment of the present invention, as shown in fig. 8, where the flowchart includes the following steps:
s31, vital sign data of the puerpera and the fetus are acquired, and infusion data of the target medicine sent by the infusion equipment are received. The detailed description refers to the corresponding related descriptions of the above embodiments, and will not be repeated here.
S32, analyzing vital sign data of the puerpera and the fetus, determining target infusion data of the target medicine and sending the target infusion data to the infusion device. The detailed description refers to the corresponding related descriptions of the above embodiments, and will not be repeated here.
S33, receiving current infusion data fed back by the infusion device. The detailed description refers to the corresponding related descriptions of the above embodiments, and will not be repeated here.
And S34, displaying vital sign data in a vital sign display area of the monitoring device, and displaying current infusion data in an infusion display area of the monitoring device.
Specifically, the infusion data includes a drug drip rate, and the step S34 may include: vital sign data is displayed in a vital sign display area of the monitoring device and a current drug drip rate is displayed in an infusion display area of the monitoring device.
For infusion data, it may include drug drip rate. As described above, the drug drip rate is obtained from the infusion device. The monitoring device can display the drug dripping speed in the infusion display area and display vital sign data acquired in real time in the vital sign display area.
For example, fig. 9 illustrates an alternative embodiment of a display interface of a monitoring device. The operator can observe real-time monitoring data of the parturient and the fetus at the interface. The vital sign display area displays real-time waveforms corresponding to vital signs, such as an electrocardiographic waveform and a uterine contraction waveform, and can also display blood oxygen data values, uterine cavity pressure data values and the like; an infusion display area displays a drug drip rate corresponding to oxytocin.
Optionally, the monitoring method may further include:
s35, labeling abnormal data in the monitoring process in response to labeling operation of the vital sign data by the operation object.
The monitoring device can provide a rapid labeling function, and when an operator can find that vital sign data is abnormal due to drug infusion in the monitoring process, the operator can label the abnormal data in the drug infusion process, and accordingly, the monitoring device can respond to the labeling operation of the operator on the abnormal vital sign data and label the abnormal data in the monitoring process.
S36, generating monitoring record information based on the infusion data of the target medicine and vital sign data of the puerperal and the fetus.
After the monitoring process is finished, the monitoring device can automatically generate monitoring record information, such as a monitoring record list, for the received data of the drug infusion data in the monitoring process and the uterine contraction characteristic values obtained by analyzing vital sign data, and store the monitoring record information into a storage space of the monitoring device or upload the monitoring record information to a central monitoring system, wherein the central monitoring system is a system for monitoring the disease states of various departments.
According to the monitoring method provided by the embodiment, the vital sign data and the current medicine dripping speed are displayed at the same time, so that medical staff can conveniently observe the influence of the medicine dripping speed on the vital sign data, a plurality of different systems are not required to be operated at the same time, and the workload of the medical staff is reduced. By labeling the abnormal data in the monitoring process, the follow-up adjustment of the infusion quantity of the medicine by analyzing the abnormal data is facilitated. After the monitoring is finished, monitoring record information is generated according to infusion data of the target medicine and vital sign data of the lying-in woman and fetus in the monitoring process, so that the electronization of the medicine record in the monitoring process is realized.
Although embodiments of the present invention have been described in connection with the accompanying drawings, various modifications and variations may be made by those skilled in the art without departing from the spirit and scope of the invention, and such modifications and variations fall within the scope of the invention as defined by the appended claims.

Claims (13)

1. A monitoring method for use in a monitoring device, the method comprising:
acquiring vital sign data of a lying-in woman and a fetus, and receiving infusion data of a target drug sent by an infusion device;
analyzing vital sign data of the parturients and the fetuses, determining target infusion data of the target drugs and sending the target infusion data to the infusion device;
receiving current infusion data fed back by the infusion device;
and displaying the vital sign data in a vital sign display area of the monitoring device, and displaying the current infusion data in an infusion display area of the monitoring device.
2. The method of claim 1, wherein analyzing vital sign data of the maternal and fetal, determining target infusion data of the target drug and transmitting the target infusion data to the infusion device, comprises:
Determining a uterine contraction characteristic value of the parturient based on the vital sign data;
when the uterine contraction characteristic value does not reach a preset value, determining the increment of a target drug based on the current uterine contraction characteristic value, and obtaining first target infusion data corresponding to the current uterine contraction characteristic value;
the first target infusion data is sent to the infusion device.
3. The method of claim 2, wherein analyzing the vital sign data of the maternal and fetal, determining target infusion data for the target drug and transmitting the target infusion data to the infusion device, further comprises:
when the uterine contraction characteristic value reaches a preset value, determining the holding quantity, the increasing quantity or the decreasing quantity of the target drug based on the current uterine contraction characteristic value to obtain second target infusion data corresponding to the current uterine contraction characteristic value;
the second target infusion data is sent to the infusion device.
4. A method according to claim 3, further comprising:
detecting whether vital sign abnormality occurs in the lying-in woman and the fetus;
when vital signs of the puerpera and the fetus are abnormal, alarm information is sent, and information for reducing the target drug infusion quantity is sent to the infusion equipment.
5. The method of claim 2, wherein analyzing the vital sign data of the maternal and fetal, determining target infusion data for the target drug and transmitting the target infusion data to the infusion device, further comprises:
detecting whether the uterine contraction frequency of the parturient exceeds a preset frequency based on the vital sign data;
and when the uterine contraction frequency of the puerpera exceeds a preset frequency, sending information for reducing or stopping the target medicine infusion quantity to the infusion device.
6. The method as recited in claim 5, further comprising:
when the current infusion data fed back by the infusion device is zero, detecting whether the uterine contraction frequency of the puerpera exceeds a preset frequency;
when the uterine contraction frequency of the puerpera exceeds a preset frequency, prompt information is sent to the operation object, and the prompt information is used for reminding the operation object to perform intervention treatment.
7. The method as recited in claim 2, further comprising:
determining a waiting time period of the parturient based on the vital sign data;
when the waiting time exceeds a preset time and the uterine contraction characteristic value does not reach the preset value, sending prompt information to an operation object;
And sending infusion starting information to the infusion device in response to the confirmation operation of the operation object on the prompt information.
8. The method of any one of claims 2-7, further comprising:
and responding to the selection operation of the operation object on the transfusion display area, and displaying the uterine contraction states of the target medicine and the puerperal women.
9. The method of claim 1, wherein the infusion data comprises a drug drip rate, wherein the vital sign data is displayed in a vital sign display area of the monitoring device, wherein the current infusion data is displayed in an infusion display area of the monitoring device, comprising:
and displaying the vital sign data in a vital sign display area of the monitoring device, and displaying the current medicine dripping speed in an infusion display area of the monitoring device.
10. The method as recited in claim 9, further comprising:
and labeling the abnormal data in the monitoring process in response to the labeling operation of the operation object on the vital sign data.
11. The method as recited in claim 1, further comprising:
monitoring record information is generated based on the infusion data of the target medicine and vital sign data of the parturient and the fetus.
12. A monitoring device, comprising:
the monitoring system comprises a display interface, a memory and a processor, wherein the display interface, the memory and the processor are in communication connection, the memory stores computer instructions, and the processor executes the computer instructions so as to execute the monitoring method of any one of claims 1-11.
13. A maternal-fetal monitoring system, comprising:
an infusion device for acquiring infusion data of a target drug;
the monitoring device of claim 12, communicatively coupled to the infusion device.
CN202210210671.5A 2022-03-04 2022-03-04 Monitoring method, monitoring equipment and mother tyre monitoring system Pending CN116726309A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210210671.5A CN116726309A (en) 2022-03-04 2022-03-04 Monitoring method, monitoring equipment and mother tyre monitoring system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210210671.5A CN116726309A (en) 2022-03-04 2022-03-04 Monitoring method, monitoring equipment and mother tyre monitoring system

Publications (1)

Publication Number Publication Date
CN116726309A true CN116726309A (en) 2023-09-12

Family

ID=87915661

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210210671.5A Pending CN116726309A (en) 2022-03-04 2022-03-04 Monitoring method, monitoring equipment and mother tyre monitoring system

Country Status (1)

Country Link
CN (1) CN116726309A (en)

Similar Documents

Publication Publication Date Title
US9693690B2 (en) Digital electronic fetal heart rate and uterine contraction monitoring system
RU2695886C2 (en) Help in setting alarm limits for patient
US20080228526A1 (en) System and method for managing history of patient and wound therapy treatment
CN103040460A (en) Monitor and monitoring parameter display method thereof
DE112014004946T5 (en) System and procedure for workflow management
CN202288276U (en) Monitor
US20230137546A1 (en) Alarm system for intravenous pump or catheter based upon fuzzy logic
CN111249567A (en) Wireless analgesia pump system
US20150286797A1 (en) System and method for administering medication
CN116726309A (en) Monitoring method, monitoring equipment and mother tyre monitoring system
CN103239208A (en) Monitor waveform display method and monitor waveform display system
EP2759979A1 (en) Drug information management device and drug information management method
CN204106007U (en) A kind of anesthesia depth monitor
CN116474210A (en) Monitoring method, monitoring equipment and mother tyre monitoring system
US20140278518A1 (en) Medical apparatus administration device and medical apparatus administration method
CN109419533A (en) Patient monitor and its interface switching method, device
CN113226402A (en) Monitor and method for combined display of physiological sign parameters and medication information thereof
CN103156578A (en) Intelligentized multi-parameter remote controller used for vital signs of patient in oxygen chamber
CN112955068A (en) Physiological parameter display method, medical device, and storage medium
US20220027018A1 (en) Monitor, and method for combined display of physiological sign parameters and medication information for same
CN109998503B (en) Intelligent monitoring and control system for painless delivery
CN205796151U (en) A kind of micro-injection pump of remote alarms
CN203107101U (en) Intelligentized multi-parameter remote control instrument for monitoring vital signs of oxygen cabin patient
CN114999597A (en) Medical follow-up system
CN115105682B (en) Method and system for guiding oxytocin to be used by continuous lactic acid monitoring

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination